nMET, A New Target in Recurrent Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|7|572-578

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.7, 2016-08, pp. : 572-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Target Antigens for Cancer Immunoprevention

By  

Current Cancer Drug Targets, Vol. 5, Iss. 3, 2005-05 ,pp. : 221-228

Bentham Science Publishers

Access to resources Recommend Favorite

Polysialyltransferase: A New Target in Metastatic Cancer

By  

Current Cancer Drug Targets, Vol. 12, Iss. 8, 2012-10 ,pp. : 925-939

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1284-1292

Bentham Science Publishers

Access to resources Recommend Favorite

New target agents in the treatment of colorectal cancer patients

By Tonini Giuseppe   Schiavon Gaia   Vincenzi Bruno   Santini Daniele  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 861-871

Informa Healthcare

Access to resources Recommend Favorite

The proteasome: a new `irrational' target for cancer treatment

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite